Impact of Chair Seat Height on the 1-Minute Sit to Stand Test Performance in Chronic Obstructive Pulmonary Disease
The Impact of Chair Seat Height on the 1-Minute Sit to Stand Test Performance in Chronic Obstructive Pulmonary Disease: a Randomized Cross-over Study
1 other identifier
interventional
55
1 country
1
Brief Summary
The 1-minute sit to stand (1-min STS) test is a standardized test which is used to examine exercise capacity in patients with chronic obstructive pulmonary disease (COPD). The chair seat height used is standardized to 46-48 cm. Using a standard seat height for all patients - irrespective of their body height - may lead to invalid estimates of functional exercise capacity. The objective of this study is to assess whether there is a difference in repetitions during the 1-min STS test if the seat height is adjusted to 90° knee joint angle or the standard height chair of 46 cm is used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2020
CompletedFirst Submitted
Initial submission to the registry
October 1, 2020
CompletedFirst Posted
Study publicly available on registry
October 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 25, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2021
CompletedJuly 21, 2021
July 1, 2021
6 months
October 1, 2020
July 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of repetitions in the 1-min STS test
difference in the amount of sit to stand repetitions in the 1-min STS test from a standard chair (46cm) or an individualized seat height chair of 90° knee joint angle
During pulmonary rehabilitation, approximately 14 days
Secondary Outcomes (1)
Sit to stand power index
During pulmonary rehabilitation, approximately 14 days
Other Outcomes (6)
Oxygen saturation
During pulmonary rehabilitation, approximately 14 days
Heart rate
During pulmonary rehabilitation, approximately 14 days
Ratings of perceived exertion
During pulmonary rehabilitation, approximately 14 days
- +3 more other outcomes
Study Arms (2)
1-min STS test: chair seat height adjusted to 90° knee flexion
EXPERIMENTALIn this experimental condition, the patient performs the 1-minute sit to stand test on an individually adjusted seat height of 90° knee joint flexion.
1-min STS test: chair seat height standardized of 46cm
ACTIVE COMPARATORIn this experimental condition, the patient performs the 1-minute sit to stand test on a standard height chair of 46cm.
Interventions
Individually adjusted chair seat height of 90° knee joint flexion
Standardized chair seat height of 46 cm
Eligibility Criteria
You may qualify if:
- Patients with diagnosed COPD according to a forced expiratory volume in 1s (FEV1) / forced vital capacity (FVC) ratio below the lower limit of normal
You may not qualify if:
- Patients who are not able to bend their knees while sitting on a standard chair (i.e., knee flexion less than 90°)
- Patients who are not able to understand the instructions of the 1-min STS test, either of language or cognitive reasons
- Patients who are unable to perform the STS test due to functional disability (i.e., being not able to rise from a chair without hand support), previous surgery, or pain according to the judgement of the responsible physician.
- Patients who did not sign the informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Thomas Rieglerlead
- University of Zurichcollaborator
Study Sites (1)
Berner Reha Zentrum
Heiligenschwendi, Canton of Bern, 3625, Switzerland
Related Publications (5)
Crook S, Busching G, Schultz K, Lehbert N, Jelusic D, Keusch S, Wittmann M, Schuler M, Radtke T, Frey M, Turk A, Puhan MA, Frei A. A multicentre validation of the 1-min sit-to-stand test in patients with COPD. Eur Respir J. 2017 Mar 2;49(3):1601871. doi: 10.1183/13993003.01871-2016. Print 2017 Mar.
PMID: 28254766BACKGROUNDYoshioka S, Nagano A, Hay DC, Fukashiro S. Peak hip and knee joint moments during a sit-to-stand movement are invariant to the change of seat height within the range of low to normal seat height. Biomed Eng Online. 2014 Mar 12;13(1):27. doi: 10.1186/1475-925X-13-27.
PMID: 24620992BACKGROUNDReychler G, Boucard E, Peran L, Pichon R, Le Ber-Moy C, Ouksel H, Liistro G, Chambellan A, Beaumont M. One minute sit-to-stand test is an alternative to 6MWT to measure functional exercise performance in COPD patients. Clin Respir J. 2018 Mar;12(3):1247-1256. doi: 10.1111/crj.12658. Epub 2017 Jun 15.
PMID: 28621019BACKGROUNDQuanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012 Dec;40(6):1324-43. doi: 10.1183/09031936.00080312. Epub 2012 Jun 27.
PMID: 22743675BACKGROUNDMiller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest. 2011 Jan;139(1):52-9. doi: 10.1378/chest.10-0189. Epub 2010 Jun 3.
PMID: 20522571BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Riegler, MSc
Berner Reha Zentrum, Heiligenschwendi
- PRINCIPAL INVESTIGATOR
Thomas Radtke, PD, Dr phil
University of Zurich
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 1, 2020
First Posted
October 8, 2020
Study Start
September 16, 2020
Primary Completion
March 25, 2021
Study Completion
March 30, 2021
Last Updated
July 21, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share